Faberco is proud to announce its recent partnership with Sinovac, a global leader in biopharmaceuticals. We seek partnerships with companies that share our vision of a future where every Filipino has access to healthcare products that address immediate health concerns and enhance the quality of life for individuals and communities. During a recent visit to Sinovac’s state-of-the-art manufacturing facility, Key Opinion Leaders (KOLs) were thoroughly impressed by the advanced technology and extensive production capabilities. They also praised Sinovac’s strong product portfolio and pipeline, highlighting the company’s commitment to serving Middle-Income Countries (MIC) and Low-Middle-Income Countries (LMIC), which aligns with our mission to meet the needs of underserved populations.
Sinovac’s exhibit hall features a well-explained vaccine manufacturing process that is accessible to a lay audience, making it easier to understand the steps from isolating key strains and components of microorganisms to delivering vaccines at vaccination sites. Each vaccine produced is backed by robust clinical data. Our strategic partnerships with industry leaders like Sinovac and our focus on innovative solutions ensure that we are always at the forefront of addressing public health issues and advancing the healthcare landscape in the Philippines.